National multicenter study of eligibility for interferon and ribavirin therapy in patients coinfected with HIV and hepatitis C

被引:0
|
作者
Bini, EJ
Currie, S
Shen, H
Brau, N
Schmidt, W
Wright, TL
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A695 / A695
页数:1
相关论文
共 50 条
  • [31] Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients
    Valerio, Laure
    Yazdanpanah, Yazdan
    Poizot-Martin, Isabelle
    Rosenthal, Eric
    Marimoutou, Catherine
    Gastaut, Jean-Albert
    Tran, Albert
    Dellamonica, Pierre
    Freedberg, Kenneth A.
    Pradier, Christian
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (01) : 50 - 55
  • [32] Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients
    Pineda, Juan A.
    Mira, Jose A.
    de los Santos Gil, Ignacio
    Valera-Bestard, Barbara
    Rivero, Antonio
    Merino, Dolores
    Giron-Gonzalez, Jose A.
    Rios-Villegas, Maria J.
    Gonzalez-Serrano, Mercedes
    Collado, Antonio
    Garcia-Garcia, Jose A.
    Carrillo-Gomez, Raquel
    Lopez-Cortes, Luis F.
    Gomez-Mateos, Jesus
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (06) : 1347 - 1354
  • [33] Adherence to Hepatitis C Virus Therapy in HIV/Hepatitis C-Coinfected Patients
    Vincent Lo Re
    Valerie Teal
    A. Russell Localio
    Valerianna K. Amorosa
    David E. Kaplan
    Robert Gross
    AIDS and Behavior, 2013, 17 : 94 - 103
  • [34] Adherence to Hepatitis C Virus Therapy in HIV/Hepatitis C-Coinfected Patients
    Lo Re, Vincent, III
    Teal, Valerie
    Localio, A. Russell
    Amorosa, Valerianna K.
    Kaplan, David E.
    Gross, Robert
    AIDS AND BEHAVIOR, 2013, 17 (01) : 94 - 103
  • [35] Interferon plus ribavirin for chronic hepatitis C HIV+ patients
    Soriano, V
    González, J
    Pérez-Olmeda, M
    García-Samaniego, J
    AIDS, 1998, 12 : S92 - S92
  • [36] Report of three cases of hyperlactacidemiae/lactic acidosis after treatment of hepatitis C with pegylated interferon and ribavirin in HIV coinfected patients
    Ramírez, MLM
    Zapata, MR
    REVISTA CLINICA ESPANOLA, 2002, 202 (10): : 543 - 545
  • [37] Short Communication: Interferon/Ribavirin Treatment for HCV Is Associated with the Development of Hypophosphatemia in HIV/Hepatitis C Virus-Coinfected Patients
    Funk, Emily K.
    Shaffer, Ashton
    Shivakumar, Bhavana
    Sneller, Michael
    Polis, Michael A.
    Masur, Henry
    Heytens, Laura
    Nelson, Amy
    Kwan, Richard
    Kottilil, Shyam
    Kohli, Anita
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (09) : 1190 - 1194
  • [38] Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus-Coinfected Patients With Compensated Liver Cirrhosis
    Mira, Jose A.
    Garcia-Rey, Silvia
    Rivero, Antonio
    de los Santos-Gil, Ignacio
    Lopez-Cortes, Luis F.
    Giron-Gonzalez, Jose A.
    Tellez, Francisco
    Marquez, Manuel
    Merino, Dolores
    Rios-Villegas, Maria J.
    Macias, Juan
    Rivero-Juarez, Antonio
    Pineda, Juan A.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (12) : 1719 - 1726
  • [39] Therapy of hepatitis C: Alpha interferon and ribavirin
    Reichard, O
    Schvarcz, R
    Weiland, O
    HEPATOLOGY, 1997, 26 (03) : S108 - S111
  • [40] Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy
    Chuang, WL
    Dai, CY
    Chang, WY
    Lee, LP
    Lin, ZY
    Chen, SC
    Hsieh, MY
    Wang, LY
    Yu, ML
    ANTIVIRAL THERAPY, 2005, 10 (01) : 125 - 133